Show simple item record

dc.contributor.authorNose, Holiness
dc.date.accessioned2015-11-05T10:07:32Z
dc.date.available2015-11-05T10:07:32Z
dc.date.issued2015
dc.identifier.citationNose, Holiness (2015). Synthesis of structurally modified dipyrromethene complexes as new photodynamic therapy agents for cancer. The 16th symposium of the natural products reseach network for eastern and central Africa (NAPRECA) 31st August to 3rd September 2015 Arusha, Tanzaniaen_US
dc.identifier.urihttp://www.napreca-tz.org/16napreca/16th_NAPRECA_Book_Abstracts.pdf
dc.identifier.urihttp://hdl.handle.net/11295/92283
dc.description.abstractThe ground - state structures and binding energies of the metal cations to dipyrromethene (DIPY) based ligands are determined using density functional theory (DFT) methods. Two lanthanide metal cations in their +3 oxid ation states are examined including: Gd 3+ and Eu 3+ . Calculations at B3LYP, BHandHLYP, and M06 levels of theory using 6 - 31G* and 6 - 311+G(2d,2p) basis sets are employed to determine the structures and theoretical estimates for the binding energies of the str ucturally modified complexes. Structures of the Gd - based complexes are compared to those of the Eu - based complexes to further assess the electronic effects on the binding energies. Also the optical and redox properties of the structurally modified DIPY wil l be investigated. In addition to theoretical studies, the effects of structural variations of DIPY on their photocytotoxicity in terms of photophysical properties and in vitro and in vivo efficacies are determined. Synthesis of DIPY based structures with different functionalities is carried out in order to improve hydrophilicity of the current structures. Synthesis of DIPY based structures with extended conjugation at the pyrollic position is performed in order to prepare photosynthesizers that absorb in t he longer wavelengths. Such complexes may be activated deeper in the tissues and may therefore be clinically favored. The photodynamic therapy (PDT) efficacy of the DIPY - based photosensitizers is tested on a panel of leukemia and solid tumor cell lines, w ith particular attention on their 56 2015 Arusha, Tanzania structure - activity relationships. The PDT efficacy of the gadolinium based DIPYs currently prepared is compared to the ones in the marketen_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleSynthesis of structurally modified dipyrromethene complexes as new photodynamic therapy agents for canceren_US
dc.typePresentationen_US
dc.type.materialenen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record